MENUNews Archive
Date: 04/28/2014
Researchers surveyed woman in Detroit and Los Angeles who had been diagnosed with early stage breast cancer. They narrowed their sample to the 746 women who reported working at the time they were diagnosed. Participants were surveyed about nine months after diagnosis, and then given a follow-up survey about four years later.
Date: 04/24/2014
Prostate cancer becomes deadly when anti-hormone treatments stop working. Now a new study suggests a way to block the hormones at their entrance.
Researchers from the University of Michigan Rogel Cancer Center have found that a protein called BET bromodomain protein 4 binds to the hormone androgen receptor downstream of where current therapies work – targeting androgen receptor signaling.
Date: 03/26/2014
Four years after being treated for breast cancer, a quarter of survivors say they are worse off financially, at least partly because of their treatment, according to a new study led by University of Michigan Rogel Cancer Center researchers.
Date: 03/21/2014
Shaomeng Wang has been selected to receive the Distinguished University Innovator Award for 2014. Sponsored by the Office of Research, the award honors faculty who have made important and lasting contributions to society by developing novel ideas and insights through their research, and then translating them to practice.
Date: 03/04/2014
A new study, authored by Reshma Jagsi, M.D., D.Phil., associate professor of radiation oncology, finds gender differences in parenting and household labor persist among a group of highly motivated physician-researchers in the early stages of their career. The finding could shed light on why female academic physicians in general do not have the same career success as their male colleagues.
Date: 02/19/2014
Researchers found that a majority of women who undergo mastectomy for breast cancer go on to get breast reconstruction, with rates rising dramatically over time. There are still geographic variations, and women who also have radiation tend to have lower rates of reconstruction.
Date: 02/18/2014
New research from the University of Michigan Rogel Cancer Center and Georgia Regents University finds that a protein that fuels an inflammatory pathway does not turn off in breast cancer, resulting in an increase in cancer stem cells. This provides a potential target for treating triple negative breast cancer, the most aggressive form of the disease.
Date: 01/15/2014
Written by Nicole Fawcett
Researchers identify two types of cancer stem cells; both necessary to create metastasis
Date: 01/06/2014
The research and development spending in the United States dropped from $131 billion to $119 billion, when adjusted for inflation, from 2007-2012, while Japan increased spending by $9 billion and China increased by $6.4 billion. Overall, Asia's share of spending grew from 18 percent to 24 percent. Europe held steady at 29 percent.